|
Status |
Public on Aug 31, 2018 |
Title |
Notch3-dependent beta-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
EGFR tyrosine kinase inhibitors cause dramatic responses in EGFR-mutant lung cancer, but resistance universally develops. The involvement of β-catenin in EGFR TKI resistance has been previously reported however the precise mechanism by which β-catenin activation contributes to EGFR TKI resistance is not clear. Here, we show that EGFR inhibition results in the activation of β-catenin signaling in a Notch3-dependent manner, which facilitates the survival of a subset of cells that we call “adaptive persisters”. We previously reported that EGFR-TKI treatment rapidly activates Notch3, and here describe the physical association of Notch3 with β-catenin, leading to increased stability and activation of β-catenin. We demonstrate that the combination of EGFR-TKI and a β-catenin inhibitor inhibits the development of these adaptive persisters, decreases tumor burden, improves recurrence free survival, and overall survival in xenograft models. These results supports combined EGFR-TKI and β-catenin inhibition in patients with EGFR mutant lung cancer.
|
|
|
Overall design |
HCC4006 cells were transfected with NTC, Notch1 or Notch3 siRNAs. Cells split into two groups, one was treated with DMSO and the other was treated with erlotinib for 5 days. Total RNA was collected and subjected to transcriptome analysis.
|
|
|
Contributor(s) |
Arasada RR, Zhang J |
Citation(s) |
30097569 |
Submission date |
Jun 15, 2018 |
Last update date |
Dec 06, 2018 |
Contact name |
Rajeswara Arasada |
E-mail(s) |
Rajeswara.Arasada@osumc.edu
|
Organization name |
Ohio State University
|
Street address |
420 W 12th Ave
|
City |
Columbus |
State/province |
OH |
ZIP/Postal code |
43211 |
Country |
USA |
|
|
Platforms (1) |
GPL17586 |
[HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version] |
|
Samples (18)
|
|
Relations |
BioProject |
PRJNA476332 |